ALVO
Closed
Alvotech
9.07
-0.05 (-0.55%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 9.12
Day's Range: 9.03 - 9.24
Send
sign up or login to leave a comment!
When Written:
12.9
Alvotech is a global biopharmaceutical company that specializes in the development and manufacturing of biosimilar products. The company was founded in 2013 and is headquartered in Reykjavik, Iceland. Alvotech has a strong focus on developing high-quality biosimilar products that are affordable and accessible to patients worldwide. The company has a team of experienced scientists and engineers who work on product development, process optimization, and manufacturing. Alvotech has a portfolio of biosimilar products that are in various stages of development, including biosimilars for adalimumab, rituximab, and bevacizumab. The company has partnerships with several leading pharmaceutical companies to bring its biosimilar products to market. Alvotech has a global presence with offices and manufacturing facilities in Iceland, Germany, and Switzerland.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








